首页 正文

Galactosylated Bilosomes for Liver-Targeted Delivery of Ledipasvir: Optimization, Conjugate Synthesis, and Cellular Evaluation

{{output}}
Ledipasvir is one of the direct-acting antiviral agents used for treating hepatitis C virus (HCV) infection. To achieve dose reduction and cost-effective therapy, this study aimed to enhance the interaction of ledipasvir with HCV-infected hepatocytes through t... ...